[Congressional Bills 106th Congress]
[From the U.S. Government Publishing Office]
[H.R. 3248 Introduced in House (IH)]







106th CONGRESS
  1st Session
                                H. R. 3248

To amend the Public Health Service Act and the Federal Food, Drug, and 
 Cosmetic Act with respect to information on the human papillomavirus 
                        (commonly known as HPV).


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                            November 8, 1999

  Mr. Coburn (for himself and Mr. Smith of New Jersey) introduced the 
    following bill; which was referred to the Committee on Commerce

_______________________________________________________________________

                                 A BILL


 
To amend the Public Health Service Act and the Federal Food, Drug, and 
 Cosmetic Act with respect to information on the human papillomavirus 
                        (commonly known as HPV).

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Protecting Women's Health Act of 
1999''.

SEC. 2. HUMAN PAPILLOMAVIRUS; ACTIVITIES OF CENTERS FOR DISEASE CONTROL 
              AND PREVENTION.

    Part B of title III of the Public Health Service Act (42 U.S.C. 243 
et seq.) is amended by inserting after section 317G the following 
section:

                         ``human papillomavirus

    ``Sec. 317H. (a) Surveillance.--
            ``(1) In general.--The Secretary, acting through the 
        Director of the Centers for Disease Control and Prevention, 
        shall--
                    ``(A) enter into cooperative agreements with States 
                and other entities to conduct sentinel surveillance or 
                other special studies that would determine the 
                prevalence in various age groups and populations of 
                specific types of human papillomavirus (referred to in 
                this section as `HPV') in different sites in various 
                regions of the United States, through collection of 
                special specimens for HPV using a variety of 
                laboratory-based testing and diagnostic tools; and
                    ``(B) develop and analyze data from the HPV 
                sentinel surveillance system described in subparagraph 
                (A).
            ``(2) Report.--The Secretary shall make a progress report 
        to the Congress with respect to paragraph (1) not later than 
        one year after the effective date of this section.
    ``(b) Prevention Activities; Education Program.--
            ``(1) In general.--The Secretary, acting through the 
        Director of the Centers for Disease Control and Prevention, 
        shall conduct prevention research on HPV, including--
                    ``(A) behavioral and other research on the impact 
                of HPV-related diagnoses on individuals;
                    ``(B) formative research to assist with the 
                development of educational messages and information for 
                the public, for patients, and for their partners about 
                HPV;
                    ``(C) surveys of physician and public knowledge, 
                attitudes, and practices about genital HPV infection; 
                and
                    ``(D) upon the completion of and based on the 
                findings under subparagraphs (A) through (C), develop 
                and disseminate educational materials for the public 
                and health care providers regarding HPV and its impact 
                and prevention.
            ``(2) Report; final proposal.--The Secretary shall make a 
        progress report to the Congress with respect to paragraph (1) 
        not later than one year after the effective date of this 
        section, and shall develop a final proposal not later than two 
        years after such effective date, including a detailed summary 
        of the significant findings and problems. The report shall 
        outline the further steps needed to make HPV a reportable 
        disease and the best strategies to prevent future infections.
    ``(c) Condom Effectiveness; Education.--The Secretary shall require 
that the Department of Health and Human Services and all contractors, 
grantees, and subgrantees of such Department specifically state the 
effectiveness or lack of effectiveness of condoms in preventing the 
transmission of HPV, herpes, and other sexually transmitted diseases in 
all informational materials related to condoms or sexually transmitted 
diseases that are made available to the public. The Secretary shall 
assure that such information is made available to relevant operating 
divisions and offices of the Department of Health and Human Services. 
This subsection shall be effective within 6 months of the date of its 
enactment.''.

SEC. 3. LABELING OF CONDOMS WITH RESPECT TO HUMAN PAPILLOMAVIRUS.

    (a) In General.--Section 502 of the Federal Food, Drug, and 
Cosmetic Act (21 U.S.C. 352) is amended by adding at the end the 
following:
    ``(u) If it is a condom, unless its label and labeling bear 
information providing that condoms do not effectively prevent the 
transmission of the human papillomavirus and that such virus can cause 
cervical cancer.''.
    (b) Applicability.--The amendment made by subsection (a) applies to 
condoms manufactured on or after the expiration of the 180-day period 
beginning on the date of the enactment of this Act.
                                 <all>